Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Aytu BioPharma, Inc. - Common Stock
(NQ:
AYTU
)
2.250
+0.050 (+2.27%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Aytu BioPharma, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Why Shapeways Holdings Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
↗
November 15, 2023
Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 15, 2023
Via
Benzinga
Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023
November 07, 2023
Via
ACCESSWIRE
Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement
October 26, 2023
Via
ACCESSWIRE
Aytu BioPharma Inc. (NASDAQ: AYTU) Near the Top of Equities by Percentage Gain on 9/28
September 28, 2023
Via
Investor Brand Network
Earnings Scheduled For February 14, 2024
↗
February 14, 2024
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is projected to report quarterly earnings at $1.65 per share on revenue of $24.62 billion.
Via
Benzinga
Earnings Preview: Aytu BioPharma
↗
February 13, 2024
Via
Benzinga
Aytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024
February 07, 2024
Via
ACCESSWIRE
Aytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
January 23, 2024
Via
ACCESSWIRE
Aytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023
November 30, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
November 22, 2023
Via
Benzinga
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
November 14, 2023
Via
ACCESSWIRE
Aytu BioPharma's Earnings: A Preview
↗
November 13, 2023
Via
Benzinga
Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year
November 08, 2023
Via
ACCESSWIRE
Aytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023
September 26, 2023
Via
ACCESSWIRE
Biggest Short Squeeze Stocks Of The Week: Biotech Stocks Dominate, A Bitcoin-Related Stock Moves Up Leaderboard
↗
November 06, 2023
Potential short squeeze plays gained steam in 2021, continued throughout 2022 and remained a focus of traders looking for the next big move. High short interest and steep borrowing costs are among the...
Via
Benzinga
Aytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023
October 09, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
September 27, 2023
Via
Benzinga
Earnings Outlook For Aytu BioPharma
↗
September 26, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Earnings Scheduled For September 27, 2023
↗
September 27, 2023
Companies Reporting Before The Bell • Paychex (NASDAQ:PAYX) is projected to report quarterly earnings at $1.12 per share on revenue of $1.29 billion.
Via
Benzinga
Aytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023
September 21, 2023
Via
ACCESSWIRE
Aytu BioPharma to Present at LD Micro Main Event XVI Conference
September 13, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
August 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 18, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
↗
August 09, 2023
Via
Benzinga
Stonegate Capital Partners Announces Publishing of a Thematic Report - Undervalued Growth Pharma Companies Amidst Healthcare Sector Decline
August 08, 2023
Dallas, Texas--(Newsfile Corp. - August 8, 2023) - Stonegate is pleased to announce the...
Via
Newsfile
Aytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian Authority
July 31, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
